Rabbit Anti-EFEMP1 Recombinant Antibody (EG1036) (CBMAB-EN1221-LY)

Collantes, E. R. A., Delfin, M. S., Fan, B., Torregosa, J. M. R., Siguan‐Bell, C., Florcruz, N. V. D. G., ... & Wiggs, J. L. (2022). EFEMP1 rare variants cause familial juvenile‐onset open‐angle glaucoma. Human mutation, 43(2), 240-252.

McGrath, E. R., Himali, J. J., Levy, D., Yang, Q., DeCarli, C. S., Courchesne, P., ... & Seshadri, S. (2022). Plasma EFEMP1 is associated with brain aging and dementia: The Framingham Heart Study. Journal of Alzheimer's Disease, (Preprint), 1-10.

Peng, X., Guo, Z., Zhang, Y., Sun, B., & Zhang, Q. (2022). EFEMP1 in direct inguinal hernia: correlation with TIMP3 and regulation toward elastin homoeostasis as well as fibroblast mobility. Journal of Investigative Surgery, 35(1), 203-211.

Garland, D. L., Pierce, E. A., & Fernandez-Godino, R. (2021). Complement C5 is not critical for the formation of sub-RPE deposits in Efemp1 mutant mice. Scientific Reports, 11(1), 1-11.

Ying, X., Liu, B., Yuan, Z., Huang, Y., Chen, C., Jiang, X., ... & Ji, W. (2021). METTL1‐m7G‐EGFR/EFEMP1 axis promotes the bladder cancer development. Clinical and translational medicine, 11(12), e675.

Cheng, L., Chen, C., Guo, W., Liu, K., Zhao, Q., Lu, P., ... & Xu, X. (2021). EFEMP1 Overexpression Contributes to Neovascularization in Age-Related Macular Degeneration. Frontiers in Pharmacology, 11, 547436.

Chen, T. J., Chan, T. C., Li, W. S., Li, C. F., Ke, H. L., Wei, Y. C., ... & Li, W. M. (2021). Utility of EFEMP1 in the prediction of oncologic outcomes of urothelial carcinoma. Genes, 12(6), 872.

Driver, S. G., Jackson, M. R., Richter, K., Tomlinson, P., Brockway, B., Halliday, B. J., ... & Wade, E. M. (2020). Biallelic variants in EFEMP1 in a man with a pronounced connective tissue phenotype. European Journal of Human Genetics, 28(4), 445-452.

Wang, Z., Kang, J., Lian, J., Huang, L., Xie, W., Zhao, D., ... & Lin, Z. (2020). EFEMP1 as a potential biomarker for diagnosis and prognosis of osteosarcoma. BioMed research international, 2020.

Cosentino, G., Romero-Cordoba, S., Plantamura, I., Cataldo, A., & Iorio, M. V. (2020). miR-9-mediated inhibition of EFEMP1 contributes to the acquisition of pro-tumoral properties in normal fibroblasts. Cells, 9(9), 2143.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols